Numerous studies have developed NAFLD risk prediction models using variables such as body mass index (BMI), alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL), and waist circumference (WC) (14, 15). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.